Ambulatory Blood Pressure Monitors Market Analysis & Forecast: 2025-2032

Ambulatory Blood Pressure Monitors Market Size

Ambulatory Blood Pressure Monitors Market size is estimated to be valued at USD 1,955.3 Mn in 2025 and is expected to reach USD 3,438.9 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 8.4% from 2025 to 2032.

Key Takeaways

• Based on Product Type, the Wrist Monitor segment is expected to hold a 56.8% market share in 2025, driven by high sensitivity and reliable reading.
• Based on End User, the Hospital segment is expected to account for highest share of the market in 2025, driven by its ability to assess a patient's overall health, and identify potential problems.
• Based on Region, North America is dominating the global ambulatory blood pressure monitors market with a 36.3% of the market share in 2025, fueled by the increasing prevalence of hypertension and rising awareness about advanced ambulatory monitors.

Market Overview

The global ambulatory blood pressure monitors market demand is gaining prominence driven by the comprehensive and accurate monitoring of a patient's blood pressure than traditional in-office measurements this approach helps to diagnose conditions like white coat hypertension and masked hypertension. It also helps in assessing the effectiveness of blood pressure medications and identifying potential risks associated with blood pressure fluctuation. The ambulatory blood pressure monitors are widely used in specific situations like pregnancy with hypertension, patients with fluctuating hypertension, or those with refractory hypertension. 

Current Events and their Impact on the Ambulatory Blood Pressure Monitors Market

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Role of Artificial Intelligence (AI) on the Ambulatory Blood Pressure Monitors Market

The integration of artificial intelligence into ambulatory blood pressure monitors market offers significant potential for improving hypertension management. AI algorithms can analyze ABPM data, including patterns of blood pressure fluctuations, to enhance diagnosis, predict risks, and personalize treatment. This includes identifying hypertension, assessing nocturnal hypertension, and analyzing nocturnal dipping, potentially freeing up clinicians' time for more complex tasks. The use of artificial intelligence (AI) for interpreting ambulatory blood pressure monitoring (ABPM) data is gaining traction in clinical practice.

In March 2025, researchers at the Korea Advanced Institute of Science and Technology (KAIST) introduced a comprehensive framework for AI-driven wearable blood pressure sensors, aiming to revolutionize cardiovascular care. Published in Nature Reviews Cardiology, the work tackles technical and clinical hurdles—including signal degradation and accuracy—to enable continuous, non-invasive 24/7 monitoring via cuffless wearables.

Reimbursement Policy Expansions in Ambulatory Blood Pressure Monitors Market

The Centers for Medicare & Medicaid Services (CMS) has expanded Remote Patient Monitoring (RPM) reimbursement codes to include rural and underserved clinic networks. This update allows qualified healthcare providers to claim up to $288 per patient per month for ABPM-related services. As a result, analysts anticipate a 31% surge in home-based ABPM device deployments across the U.S., particularly in areas with limited access to traditional diagnostic infrastructure. This expansion is pivotal for early hypertension detection and aligns with broader public health strategies aimed at reducing cardiovascular risk in rural populations.

In Japan, recent reforms under its national health insurance policy now include coverage for remote ABPM devices under telemedicine services. This update is expected to unlock the market opportunity, particularly in highly urbanized and tech-forward regions such as Osaka and Tokyo. By allowing physicians to monitor patients remotely, these reforms not only improve chronic disease management but also reduce hospital visits and related costs. The integration of ABPM into Japan’s telehealth model underscores a growing shift toward personalized, preventive care in advanced economies.

Together, these policy moves signify a structural shift in how chronic disease diagnostics are reimbursed and deployed, positioning ABPM as a frontline tool in hypertension and cardiovascular disease prevention globally.

Segmental Insights

To learn more about this report, Request sample copy

Ambulatory Blood Pressure Monitors Market Insights, Product Type

Wrist Monitors Acquires the Largest Market Share Owing to its High Sensitivity and Reliable Reading

In terms of product type, the wrist monitors segment is expected to contribute 56.8% share of the market in 2025 owing to its high sensitivity and reliable reading. The wrist blood pressure monitors primarily centered around convenience and portability. They are generally smaller, lighter, and more discreet than traditional upper arm monitors, making them ideal for travel and on-the-go use. Additionally, wrist monitors can be more comfortable for individuals with larger arms or those who find the pressure of an upper arm cuff uncomfortable. Some wrist blood pressure monitors may be accurate when used exactly as directed and checked against measurements taken in a medical office.

In June 2025, according to IDC’s Worldwide Quarterly Wearable Device Tracker, Huawei claimed the No. 1 spot in the global wrist-worn device market during Q1 2025, driven by strong growth and dominance in China. The milestone also marked 200 million cumulative shipments worldwide as of June 5. Huawei’s diverse portfolio including Watch 5, Watch Fit 4 Pro, GT series, and blood-pressure-enabled Watch D, cater to users across smart-living, fitness, health, and professional-use scenarios. The company’s upgraded TruSense system enhances vital-sign accuracy, reflecting Huawei’s commitment to smart healthcare and wearable innovation.

Ambulatory Blood Pressure Monitors Market Insights, End User

Hospital Dominates the Overall Market

In terms of end user, the hospital segment is projected to contribute the highest share of the market in 2025, driven by ability to assess a patient's overall health, identify potential problems, and guide treatment decisions. Blood pressure measurements are crucial for diagnosing and managing conditions like hypertension (high blood pressure) and hypotension (low blood pressure), and for monitoring the effectiveness of treatments. Checking the blood pressure at hospitals is essential as it can determine any signs of underlying medical conditions such as heart disease, stroke risk internal bleeding, or dehydration. Blood pressure readings also play a key role in managing chronic illnesses such as diabetes, kidney disease, and heart failure, allowing healthcare providers to make informed decisions about medications and treatment plans. Regular monitoring helps in preventing serious complication by enabling early intervention when slight abnormal values are detected.

In May 2025, Katz Women’s Hospital at LIJMC launched a specialized cardiology program addressing women’s heart health, focusing on the diagnosis and treatment of Ischemia with Non-Obstructive Coronary Arteries (INOCA)—a condition where women experience chest pain without major artery blockages. This is further anticipated to add to the ambulatory blood pressure monitors market share.

Regional Insights

To learn more about this report, Request sample copy

North America Ambulatory Blood Pressure Monitors Market Analysis & Trends

North America is estimated to be the largest market for ambulatory blood pressure monitors during the forecast period, accounting for over 36.30% of the market share in 2025. The market growth in North America is due to the increasing prevalence of hypertension and rising awareness about advanced ambulatory monitors. Hypertension affects nearly one in four Canadian adults between the ages of 20 and 79. This is further accelerating the ambulatory blood pressure monitors market growth.

The growing geriatric population, who are more susceptible to hypertension. According to recent ambulatory blood pressure monitors market research, a recent primary-care report revealed growing use of ABPM as a point-of-care diagnostic tool, including pediatric hypertension detection—highlighting broader clinical acceptance. As both public health initiatives and provider infrastructure support expanded ABPM use, North America remains the clear leader, while home-based monitoring continues to gain traction under evolving reimbursement and telehealth frameworks.

Asia Pacific Ambulatory Blood Pressure Monitors Market Analysis & Trends

Asia Pacific is the fastest-growing market for cervical cancer vaccines. The Asia Pacific region represents a major opportunity for market players in the ambulatory blood pressure monitors industry. With rising healthcare expenditures and a growing focus on preventive healthcare, the demand for blood pressure monitoring devices is increasing rapidly across several countries. For instance, by 2035, government health spending per person in India is expected to rise to USD 62.84. China and India are expected to be the fastest growing markets due to their huge patient bases and improving access to diagnostic services. Growing awareness about hypertension and its management. The ambulatory blood pressure monitors market forecast indicates the incorporation of governments in the region expanding diagnostic infrastructure and promote remote monitoring, deployment of home and clinic-based ABPM devices is accelerating—strengthening the market outlook in China, India, and beyond.

Ambulatory Blood Pressure Monitors Market Outlook Country-Wise

The United States Ambulatory Blood Pressure Monitors Market

The U.S. ambulatory blood pressure monitors market is characterized by high prevalence of hypertension, the need to accurately diagnose hypertension, and the desire to optimize treatment strategies. In the United States, nearly half of all adults (approximately 119.9 million) have hypertension, also known as high blood pressure. This condition is a major risk factor for heart disease and stroke, which are leading causes of death.  According to Centers for Disease Control and Prevention, nearly 48% of U.S. adults has hypertension in 2023.

In January 2025, the American Heart Association (AHA) and American Medical Association (AMA) relaunched their Target:BP™ Initiative, aiming to improve hypertension outcomes for over 9 million Americans. The campaign focuses on four pillars: accurate blood pressure measurement, timely clinical intervention, self‑measured patient monitoring, and patient partnership.

India Ambulatory Blood Pressure Monitors Market

India ambulatory blood pressure monitors market is experiencing significant growth in recent years, driven by public health insurance schemes. Pradhan Mantri Jan Arogya Yojana (PM-JAY), is set to add 500 million newly insured beneficiaries, triggering a significant surge in demand for cost-effective diagnostic tools. Among these, Ambulatory Blood Pressure Monitoring (ABPM) devices—used for diagnosing and managing hypertension—are expected to see a dramatic uptick, especially under the program’s cost-efficiency mandates.

Additionally, with a strict price ceiling of USD 150 (approx. ₹12,500) per device for reimbursement eligibility, domestic medical technology manufacturers are now focusing on producing low-cost, rugged, and user-friendly ABPM solutions tailored to rural and semi-urban healthcare settings. The expansion not only amplifies access to advanced cardiovascular monitoring tools but also encourages local innovation and scaled production under India’s "Make in India" healthcare initiative.

Market Report Scope

Global Ambulatory Blood Pressure Monitors Market Trends

• Wireless connectivity in ABPM devices: The wireless connectivity in ambulatory blood pressure monitoring (ABPM) devices is having a profound impact on the market. With advancements in Bluetooth and internet of things (IoT) technology, newer ABPM devices are able to seamlessly and securely transmit a patient's blood pressure readings in real-time to their physician's clinic via a mobile application. This connectivity enables remote patient monitoring and makes the diagnostic process more convenient and efficient. Physicians can review readings almost immediately as they are measured throughout a patient's daily routine. Any aMnormal values can be identified and addressed quickly without unnecessary additional in-person visits. The wireless capabilities also allow device makers to offer software features like automated reports and data analytics tools to clinicians.
• Remote monitoring and cloud-based data analysis: The remote monitoring and cloud-based data analysis trend is having a notable impact on the ambulatory blood pressure monitor (ABPM) market. With advanced technologies allowing doctors to monitor patients' blood pressure readings remotely through wireless devices that transfer data through apps or secure web portals, it is significantly improving medical care while also driving new opportunities for ABPM manufacturers. This remote monitoring capability is enabling far more widespread use of ABPM as it removes the need for patients to schedule separate in-office visits or trips solely for the purpose of having their doctor download and analyze the blood pressure readings. With data automatically uploaded to the cloud, physicians can check on their patients' blood pressure trends remotely at any time without the patient needing to come to the office. This level of convenience is appealing both to providers and patients.

Global Ambulatory Blood Pressure Monitors Market Drivers

• Rising prevalence of hypertension: Rising prevalence of hypertension or high blood pressure is a major risk factor driving the growth of the global ambulatory blood pressure monitors market. For instance, according to data published by World Health Organization (WHO) in March 2023, an estimated 1.28 billion adults aged 30–79 years worldwide have hypertension, most (two-thirds) living in low- and middle-income countries
• Rising awareness about ambulatory blood pressure monitoring (ABPM) benefits: Rising awareness about the benefits of ambulatory blood pressure monitoring (ABPM) is a key factor driving the growth of the global ambulatory blood pressure monitors market. ABPM provides a more comprehensive picture of an individual's blood pressure over an extended period of time. Unlike conventional blood pressure readings taken in a clinical setting, which may be elevated due to visit-related anxiety known as white coat hypertension, ABPM enables monitoring of blood pressure during normal daily activities and periods of rest. This helps detect masked hypertension which cannot be picked up through conventional measurement methods and poses health risks. More healthcare professionals are recognizing the value of ABPM in improving cardiovascular risk-stratification and management of hypertension. Medical guidelines from bodies like the American Heart Association recommend use of ABPM for confirmation of diagnoses in certain cases.
• Technological advancements in BP monitoring devices: Technological advancements are significantly driving the growth of ambulatory blood pressure monitor (ABPM) market. ABPMs help improve hypertension diagnosis and management by enabling continuous monitoring of blood pressure throughout the day and night over 24–48-hour periods. Advancements like smaller, lightweight and wearable devices have made ABPM more convenient for long-term use. They can easily be worn under clothes and allow patients to go about their normal activities. This has helped increase adoption among those needing frequent monitoring.

Global Ambulatory Blood Pressure Monitors Market Opportunities

• Untapped emerging markets: Untapped emerging markets have immense potential to become a great opportunity for growth in the ambulatory blood pressure monitor market. Countries like India, Indonesia, Brazil, Mexico, and parts of Africa are experiencing rapid economic development and rise in income levels. Countries like China, India, and Brazil with huge population bases and growing middle class are witnessing growing incidences of hypertension due to genetic predisposition and changes in diet and lifestyle towards processed food, less physical activity, obesity and stress. This has created a heavy burden on public healthcare and increased demand for monitoring devices to facilitate self-care at home to reduce pressure on hospitals and clinics
• Integration of mHealth with ABPM devices: The integration of mobile health (mHealth) technologies with ambulatory blood pressure monitoring (ABPM) devices offers tremendous potential for the ABPM market in the near future. As high blood pressure has become a growing public health problem worldwide, advanced monitoring outside of clinical settings is crucial to improve management. Combining ABPM's ability to capture multi-day BP readings with mHealth's connectivity allows clinicians to remotely track patients and identify irregularities in near real-time. This helps optimize treatment regimens and lifestyle interventions.

Key Developments

• In June 2025, At the European Society of Hypertension (ESH) conference in Milan, South Korean startup Sky Labs introduced the ring-type cuffless blood pressure monitor. The wearable enables 24-hour monitoring with no disruption to daily life, addressing limitations of traditional cuff-based devices, according to Professor Hae-Young Lee.
• In April 2025, BD (Becton, Dickinson and Company) unveiled its HemoSphere Alta™, a next-generation hemodynamic monitoring system powered by AI to support clinical decision-making in critical care.
• In January 2025, Scottish tech firm Novosound unveiled the world’s first ultrasound-based cuffless blood pressure monitors at CES 2025, marking a milestone in wearable health technology. Built on their Slanj platform using thin-film ultrasound, the device achieves accuracy comparable to standard cuff systems while offering 24/7 real-time monitoring without disruption to daily activities.
• In July 2024, Smart Meter introduced its new iBloodPressure Classic Multi-Cuff Monitor, a cellular-connected blood pressure device featuring three cuff sizes (large, XL, XXL) to accommodate arm diameters from 8.6 to 20.5 inches—enhancing both precision and inclusivity for remote patient monitoring and chronic care management. The advanced monitor sends encrypted readings via cellular RPM™ for real-time tracking, helping healthcare professionals’ access detailed patient blood pressure trends without compromising accuracy due to poor cuff fit.
• In May 2023, Aktiia, a health tech startup transforming hypertension care, announced promising results from a preliminary study comparing their cuff-less and continual blood pressure monitor with traditional ambulatory blood pressure monitors (ABPM). The study included 52 patients enrolled in a 12-week cardiac rehabilitation program and found that the Aktiia bracelet produced daytime blood pressure measurements that were comparable to those of an ABPM.

Analyst Opinion (Expert Opinion)

The Ambulatory Blood Pressure Monitors (ABPM) market value is entering a strategic inflection point—not due to sheer demand volume, but because of regulatory decentralization, payer shifts, and technology redefinition. The clinical superiority of ABPM in detecting white-coat hypertension and nocturnal dipping patterns has been established for over a decade, yet its real market unlock is just beginning, driven by payer-led remote monitoring initiatives and a decisive move away from in-clinic blood pressure assessments.

The Centers for Medicare & Medicaid Services (CMS) has already catalyzed adoption by expanding coverage for ABPM under Remote Physiologic Monitoring (RPM) codes, particularly targeting rural clinics and patients with episodic hypertension. This is not a marginal change—it structurally alters how blood pressure is managed in hypertensive populations. According to the American Heart Association, over 20% of diagnosed hypertension cases are white-coat in nature. ABPM is now a clinical and reimbursement imperative, not a luxury.

Private insurers are following suit. UnitedHealthcare and Blue Cross Blue Shield have introduced performance-based reimbursement models where ABPM outcomes—especially in resistant hypertension—determine continuity of coverage for medication plans. In essence, the payer system is coercing clinical decision-making toward ABPM validation.

Technologically, the market is bifurcating into traditional cuff-based ABPMs and cuffless, wearable-enabled continuous monitoring devices. While cuff-based systems like Spacelabs and Welch Allyn dominate the clinical segment, startups like Sky Labs (Korea) and Aktiia (Switzerland) are defining algorithm-driven, cloud-connected ABPMs with high-frequency sampling. For instance, Sky Labs’ CART-I ring has been validated in multi-country trials and shows promising convergence between wearability and accuracy, with 91.4% correlation against standard ABPMs in a 2024 peer-reviewed study.

The biggest overlooked force? Electronic Health Record (EHR) integration. Devices that offer FHIR-compatible APIs are becoming default choices in hospital purchasing cycles. In the U.S., more than 70% of hospitals require remote patient monitoring devices to sync with Epic or Cerner, and this is creating a data gravity effect, where a handful of monitor OEMs are absorbing institutional demand due to EHR-compatibility alone.

Market Segmentation

• Global Ambulatory Blood Pressure Monitors Test Market, By Product Type
  • Wrist Monitors
  • Arm Monitors
• Global Ambulatory Blood Pressure Monitors Test Market, By End User
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Others  
• Global Ambulatory Blood Pressure Monitors Test Market, By Region
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Top Companies in the Global Ambulatory Blood Pressure Monitors Market
  • OSI Systems Inc.
  •  SunTech Medical Inc.
  •  Andon Health Co. Ltd.
  •  Schiller AG
  •  Omron Healthcare Co. Ltd.
  •  Beurer GmBH
  •  Finapres Medical Systems B.V.
  •  Welch Allyn, Inc.
  •  Koninklijke Philips N.V.
  • Aktiia
  • Biobeat
  • LiveMetric
  • CardiAI Inc.

Sources

Primary Research Interviews from the following stakeholders
Stakeholders

• Interviews with medical device manufacturers, cardiologists, nephrologists, procurement managers, home healthcare providers, telehealth service operators, and remote patient monitoring coordinators across key global markets.

Databases

• World Health Organization (WHO) Medical Device Statistics
• UN Comtrade – HS Codes for BP Monitoring Devices
• U.S. Food and Drug Administration (FDA) – Device Registration & Classification Database
• European Medicines Agency (EMA) – Medical Device Approvals
• Ministry of Health, Labour and Welfare (Japan)
• Central Drugs Standard Control Organization (CDSCO), India
• China National Medical Products Administration (NMPA)
• Global Trade Atlas – Medical Instrument Exports

Magazines

• MedTech Insight
• Medical Design & Outsourcing
• HealthTech Magazine
• Medical Device and Diagnostics Industry (MD+DI)
• Electronic Health Reporter
• Clinical Lab Products (CLP)
• Biotechniques – Medical Devices
• Medical Product Outsourcing (MPO)

Journals

• Journal of Human Hypertension
• Blood Pressure Monitoring (Wolters Kluwer)
• Journal of Clinical Hypertension
• IEEE Journal of Biomedical and Health Informatics
• International Journal of Medical Informatics
• Journal of Telemedicine and Telecare
• European Heart Journal – Digital Health

Newspapers

• The Wall Street Journal – Health & Science
• The Economic Times – Healthcare & Pharma
• The Hindu Business Line – Medical Devices
• Financial Times – Global Health Markets
• Business Standard – Healthcare Startups
• Nikkei Asia – Medical Technology
• South China Morning Post – Digital Health Innovation

Associations

• American Heart Association (AHA)
• European Society of Hypertension (ESH)
• International Society of Hypertension (ISH)
• Medical Device Innovation Consortium (MDIC)
• Health Information and Management Systems Society (HIMSS)
• Association of Telemedicine Service Providers
• Indian Medical Device Industry Association (IMDI)
• Asia Pacific Medical Technology Association (APACMed)

Public Domain Sources

• Ministry of Health and Family Welfare (India)
• Health Resources and Services Administration (HRSA), U.S.
• European Commission – Health Technology Assessments (HTA)
• Central Bureau of Health Intelligence (CBHI), India
• Office for National Statistics (UK) – Health Devices Segment
• National Health Commission (China)
• National Digital Health Mission (NDHM), India
• Reserve Bank of India (RBI) – Health Sector Investment Reports

Proprietary Elements

• CMI Data Analytics Tool, and Proprietary CMI Existing Repository of information for last 8 years

Definition: Ambulatory blood pressure monitoring (ABPM) involves measuring a patient's blood pressure at regular intervals over a 24-hour period by using a portable monitor. There are two main types of ambulatory blood pressure monitors - wrist ABPM devices and arm cuff ABPM devices. Wrist ABPM devices are worn on the wrist like a watch and non-invasively measure blood pressure through the wrist. Arm cuff ABPM devices utilize a standard blood pressure cuff that is worn on the upper arm. These devices automatically inflate and measure blood pressure at preset time intervals.